Takeda Pharmaceutical Company Ltd

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: -

Established: 1925-01-01

Employees: -

Market Cap: $47.5B

Website: http://www.takeda.co.jp/

Clinical Trials

A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in Argentina

Completed

Conditions: Angioedemas, Hereditary

First Posted Date: 2021-07-09

Last Posted Date: 2023-10-04

Lead Sponsor: Takeda

Target Recruit Count: 48

Registration Number: NCT04955964

Locations: 🇦🇷
Ic Projects Srl, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

Completed

Conditions: Hemophilia A

First Posted Date: 2021-07-07

Last Posted Date: 2023-07-11

Lead Sponsor: Takeda

Target Recruit Count: 94

Registration Number: NCT04953000

Locations: 🇷🇺
Children's Regional Clinical Hospital, Khabarovsk, Russian Federation
🇷🇺
State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation
🇷🇺
City Polyclinic No. 37, St. Petersburg, Russian Federation

and more 10 locations

A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

Active, not recruiting

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)

First Posted Date: 2021-06-29

Last Posted Date: 2024-10-14

Lead Sponsor: Takeda

Target Recruit Count: 224

Registration Number: NCT04943796

Locations: 🇨🇦
Pacific Coast Recovery Care, Burnaby, British Columbia, Canada
🇨🇦
Hopital de Psychiatrie de Trois-Rivières, Pavillon St-Joseph, Trois-Rivières, Quebec, Canada
🇨🇦
Regina Mental Wellness Clinic, Regina, Saskatchewan, Canada

and more 11 locations

A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.

Completed

Conditions: Hemophilia A

Interventions: Biological: PEGylated Recombinant Factor VIII

First Posted Date: 2021-06-28

Last Posted Date: 2024-11-15

Lead Sponsor: Takeda

Target Recruit Count: 16

Registration Number: NCT04941898

Locations: 🇯🇵
Takeda Selected Site, Tokyo, Japan

A Study of Surgical Interventions in Fistulizing Conditions

Active, not recruiting

Conditions: Complex Cryptoglandular Fistula
Complex Perianal Fistula
Crohns Disease
Fistula
Rectovaginal Fistula

First Posted Date: 2021-06-25

Last Posted Date: 2024-04-30

Lead Sponsor: Takeda

Target Recruit Count: 750

Registration Number: NCT04940611

Locations: 🇫🇷
CHU de Rouen - Hopital Charles Nicolle, Rouen Cedex, Seine Maritime, France
🇨🇿
Fakultni nemocnice Olomouc, Olomouc, Czechia
🇬🇧
Broomfield Hospital, Chelmsford, Essex, United Kingdom

and more 38 locations

A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

Phase 3

Completed

Conditions: Dravet Syndrome (DS)

Interventions: Drug: Placebo
Drug: Soticlestat

First Posted Date: 2021-06-25

Last Posted Date: 2025-01-01

Lead Sponsor: Takeda

Target Recruit Count: 144

Registration Number: NCT04940624

Locations: 🇺🇦
CNPE Clinical Hospital Psychiatry of the Executive Body of the Kyiv City Council KCSA, Kyiv, Ukraine
🇯🇵
Kumamoto-Ezuko Medical Center for The Severely Disabled, Kumamoto-Shi, Kumamoto, Japan
🇨🇦
Alberta Childrens Hospital, Calgary, Alberta, Canada

and more 63 locations

A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

Phase 3

Completed

Conditions: Lennox Gastaut Syndrome (LGS)

Interventions: Drug: Soticlestat
Drug: Placebo

First Posted Date: 2021-06-24

Last Posted Date: 2024-08-21

Lead Sponsor: Takeda

Target Recruit Count: 270

Registration Number: NCT04938427

Locations: 🇺🇸
St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States
🇭🇺
Pecsi Tudomanyegyetem, Pecs, Baranya, Hungary

and more 95 locations

Assessment of Updated Educational Materials for Instanyl®

Completed

Conditions: Cancer Pain
Pain

First Posted Date: 2021-06-24

Last Posted Date: 2023-08-01

Lead Sponsor: Takeda

Target Recruit Count: 536

Registration Number: NCT04938440

Locations: 🇺🇸
Central Contact, Cambridge, Massachusetts, United States

Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms

Withdrawn

Conditions: Coronavirus Disease (COVID-19)

Interventions: Biological: COVID-19 Vaccine

First Posted Date: 2021-05-19

Last Posted Date: 2022-07-28

Lead Sponsor: Takeda

Registration Number: NCT04892888

Locations: 🇯🇵
Takeda Selected Site, Tokyo, Japan

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice

Completed

Conditions: Crohns Disease
Colitis, Ulcerative
Inflammatory Bowel Diseases

First Posted Date: 2021-05-18

Last Posted Date: 2024-10-16

Lead Sponsor: Takeda

Target Recruit Count: 99

Registration Number: NCT04890262

Locations: 🇦🇹
Medizinische Universitat Graz, Graz, Austria
🇦🇹
Medizinische Universitat Innsbruck, Innsbruck, Austria
🇦🇹
Krankenhaus der Barmherzigen Bruder, St. Veit/Glan, Austria

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy